Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DermTech Inc DMTKQ

DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma... see more

Recent & Breaking News (OTCPK:DMTKQ)

DermTech Welcomes Adelle Walker as Vice President of Consumer Products

Business Wire February 23, 2022

DermTech to Announce Fourth Quarter and Full-Year Financial Results

Business Wire February 15, 2022

DermTech Management to Participate in Upcoming Investor Conferences

Business Wire January 31, 2022

BioIQ and DermTech Enter into an Agreement to Add Non-invasive DermTech Melanoma Test to BioIQ's Health Testing Solution Lineup

PR Newswire December 15, 2021

DermTech Unveils DermTech Stratum, an Expanded Translational Medicine Service Offering for Non-invasive Biomarker Analysis

Business Wire November 29, 2021

DermTech Presents Precision Approaches to Personalized Dermatology at 2021 Dermatology Drug Development Summit

Business Wire November 18, 2021

DermTech Reports Third Quarter 2021 Financial Results

Business Wire November 9, 2021

DermTech and DermatologistOnCall Enter Agreement to Improve Access to the DermTech Melanoma Test with Noninvasive, At-Home Sample Collection

Business Wire November 8, 2021

DermTech Management to Participate in Upcoming Investor Conferences

Business Wire November 2, 2021

DermTech to Announce Third Quarter Financial Results on November 9, 2021

Business Wire October 26, 2021

DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit

Business Wire October 11, 2021

DermTech Announces New Appointment of L'Oréal USA Leader Nathalie Gerschtein Keraudy to its Board of Directors

Business Wire October 4, 2021

DermTech Sponsors San Diego Open; Partners with Tennis Pro Brandon Nakashima to Raise Awareness for Sun Safety

Business Wire September 27, 2021

DermTech Study, "Non-Invasive Detection of Genomic Atypia Increases Real-World NPV and PPV of the Melanoma Diagnostic Pathway and Reduces Biopsy Burden," Published in SKIN: The Journal Of Cutaneous Medicine

Business Wire September 14, 2021

DermTech Management to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

Business Wire September 8, 2021

DermTech to Present at Florida Association of Health Plans 2021 Annual Conference

Business Wire September 2, 2021

DermTech Management to Participate at the Lake Street 2021 BIG5 Conference

Business Wire August 31, 2021

DermTech Reports Second Quarter 2021 Financial Results

Business Wire August 4, 2021

DermTech to Announce Second Quarter Financial Results on August 4, 2021

Business Wire July 21, 2021

DermTech Announces New San Diego Headquarters

Business Wire July 21, 2021